RiboX Therapeutics
PrivateLast Round
VC Round
Jul 5, 2022
Company Overview
RiboX Therapeutics is a biotechnology company that focuses on the discovery and development of fully engineered circular RNA therapeutics, a new class of RNA medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RiboX Therapeutics Comparables
Compare RiboX Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CirCode Biomedicine | 87% | |
| Therorna Inc. | 86% | |
| Shanghai CirCode Biomed Co. Ltd. | 85% | |
RiboX Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 5, 2022 |
RiboX Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | VC Round |
| Boehringer Ingelheim | VC Round |
| Eisai Innovation | VC Round |
| Lilly Asia Ventures | VC Round |
| Qiming Venture Partners | VC Round |
| Vivo Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 5, 2022
$110M raised from Boehringer Ingelheim Venture Fund, Eisai Innovation, and Temasek.
RiboX Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RiboX Therapeutics's valuation, stock price, and market status.